Zobrazeno 1 - 10
of 2 618
pro vyhledávání: ''
Publikováno v:
Future Oncology. 17:4091-4099
Aim: This study was conducted to evaluate the efficacy of immune checkpoint inhibitors (ICIs) plus anlotinib versus anlotinib alone to provide guidance for clinical treatment of non-small-cell lung cancer. Patients & methods: The records of 139 patie
Autor:
Nicola Longo, Daniela Terracciano, Francesco Del Giudice, Giuseppe Lucarelli, Angelo Porreca, Pasquale Ditonno, Angelo Luciano, Carlo Buonerba, Alessandro Antonelli, Vincenzo Caputo, Rocco Damiano, Pasquale Dolce, Michele Marchioni, Fabio Crocerossa, Paolo Gontero, Stefania Zamboni, Matteo Manfredi, Antonio Verde, Michele Battaglia, Dario Ribera, Francesco Porpiglia, Gennaro Musi, Francesco Cantiello, Andrea Minervini, Felice Crocetto, Ottavio De Cobelli, Giuseppe Celentano, Vincenzo Cosimato, Mihai Dorin Vartolomei, Nicolae Crisan, Andrea Mari, Giorgio Ivan Russo, Abdal Rahman Abu Farhan, Francesco Greco, Francesco Soria, Francesco Chiancone, Luca Scafuri, Paola Del Prete, Rodolfo Hurle, Pietro De Placido, Giuseppe Di Lorenzo, Sergio Facchini, Matteo Ferro, Riccardo Autorino, Sisto Perdonà, Gian Maria Busetto
Publikováno v:
Future Oncology. 17:3987-3994
The objective of the current research was to explore the potential prognostic value of readily available clinical and pathologic variables in bladder cancer. The novel association found between cholesterol levels and prognosis may provide the rationa
Autor:
Cornelia Mauch, Oana D. Persa
Publikováno v:
Future Oncology. 17:3809-3817
Background: When patients with advanced melanoma progress after MAPK inhibitor (MAPKI) and immune checkpoint inhibitor (ICI) treatment, they can either undergo chemotherapy or rechallenge with previously used treatments. Methods: The outcomes of 48 p
Publikováno v:
Future Oncology. 17:3925-3940
Aims: This study aimed to retrospectively determine the influence factors and survival effects of chemotherapy in pathological T3N0M0 esophageal cancer (EC) patients based on histological type. Methods: A total of 1136 pathological T3N0M0 EC patients
Autor:
Nadine El Kassis, David Atallah, Clement El Khoury, Georges Chahine, M Moubarak, Emilia Cortbaoui, Wissam Arab
Publikováno v:
Future Oncology. 17:3843-3852
The current study was designed to compare oncological outcomes between oncoplastic (OBCS) and conventional breast-conserving surgery (BCS). Data collected retrospectively from two groups of patients diagnosed with breast cancer, cases group (OBCS) an
Autor:
Adel El-Badrawy
Publikováno v:
Breast Disease. 40:275-281
BACKGROUND: Multiple primary malignancies are two or more malignancies in an individual without any relationship between the tumors. The development of improved diagnostic techniques, increased survival of cancer patients and the growing life expecta
Autor:
Giovanni Pierorazio, Francesco Pavese, Giampiero Porzio, Katia Cannita, V. Cocciolone, Lucilla Verna, Silvia Rotondaro, Corrado Ficorella, Tina Sidoni, Alessandro Parisi
Publikováno v:
Breast Disease. 40:257-262
BACKGROUND: Despite the increase in chances of cure for early breast cancer (EBC) patients, approximately 20–45% of them will experience a disease recurrence, particularly bone metastases in 60–80% of cases, which occur more frequently in luminal
Autor:
Atanas Ignatov, Piotr Czapiewski, Thomas Kalinski, Willi Pieper, Norbert Nass, Johannes Haybaeck
Publikováno v:
Cancer Biomarkers. 32:161-173
BACKGROUND: Neuronatin (NNAT) determined by immunohistochemistry is a negative prognostic biomarker for breast cancer, independent of the major clinicopathological markers. OBJECTIVE: Here, we investigated whether NNAT is also a predictive biomarker
Autor:
Dunia de Miguel, Dorothy Romanus, Shelby Corman, Courtney Johnson, Ernesto Pérez Persona, Marta Grande, Katharina Verleger, Dasha Cherepanov, Jose Angel Hernandez-Rivas, José Maria Arguiñano Pérez, Mario Arnao, Araceli Rubio, Esther González Garcia
Publikováno v:
FUTURE ONCOLOGY
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Zaguán. Repositorio Digital de la Universidad de Zaragoza
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Lay abstract This study describes treatment patterns and outcomes in newly diagnosed multiple myeloma (NDMM) patients in Spain who were not candidates for transplant. The study looked at two patient groups: patients diagnosed between 1 January 2012 a
Autor:
Line Wergeland, Siv Lise Bedringaas, Peter J. M. Valk, Adil Al Hinai, Atle Brendehaug, Monica Hellesøy, Caroline Engen, Tim Grob, Bjørn Tore Gjertsen, Randi Hovland
Publikováno v:
Molecular Oncology, 15(9), 2300-2317. John Wiley & Sons Ltd.
Molecular Oncology
Molecular Oncology, Vol 15, Iss 9, Pp 2300-2317 (2021)
Molecular Oncology
Molecular Oncology, Vol 15, Iss 9, Pp 2300-2317 (2021)
Recurrent somatic internal tandem duplications (ITD) in the FMS‐like tyrosine kinase 3 (FLT3) gene characterise approximately one third of patients with acute myeloid leukaemia (AML), and FLT3‐ITD mutation status guides risk‐adapted treatment s